Clinical Trial Update: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors [Phase 1]

View source ↗

Summary

Phase 1a/b study evaluating the safety, pharmacokinetics, and preliminary efficacy of ZL-6201 in patients with sarcoma and selected solid tumors; study is activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Solid Tumor

Drugs mentioned

• ZL-6201 (ZL-6201)

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Solid Tumors, Sarcomas | Phase 1 | Status: RECRUITING